Click HereTherapeutic Options not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
Prolongation of the QT interval is a well-established risk factor that predicts increased mortality from sudden cardiac death.1 Identification of patients with the highest risk of QT prolongation and associated adverse outcomes has been facilitated…
Two drugs newly marketed in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the QTdrugs list in the Possible Risk of TdP category. They will also be added to the list of…
AZCERT is proud to announce its participation in a multi-stakeholder collaboration with scientists from the University of Arizona, University of Utah, Purdue University and Banner Health to develop and disseminate a clinical decision support program…
The COVID-19 vaccines that are rolling out across the US and the world are our only hope for ending the global pandemic. While other precautions, like covering your mouth and nose with a mask and staying at least 6 feet away from others will still…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
